+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Coronary Artery Disease Treatment Devices Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989780
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Coronary Artery Disease Treatment Devices Market grew from USD 4.58 billion in 2024 to USD 4.84 billion in 2025. It is expected to continue growing at a CAGR of 5.78%, reaching USD 6.41 billion by 2030.

Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide, driving continuous innovation in interventional cardiology devices. Advances in catheter design, guidewire flexibility, stent coatings and bio‐absorbable materials have revolutionized treatment paradigms over the past decade. As clinicians adopt minimally invasive approaches, patient outcomes have improved significantly through reduced procedure times and lower complication rates. Yet the landscape is far from static. Ongoing breakthroughs in digital imaging, atherectomy technologies and drug‐eluting platforms promise further optimization, while demographic shifts and regulatory dynamics demand agile strategies from manufacturers and healthcare providers alike. This executive summary synthesizes critical developments in the CAD treatment device market, exploring how evolving clinical needs, trade policies and end‐user preferences shape opportunities and challenges. By highlighting transformative shifts, tariff impacts, segmentation insights, regional dynamics, and key competitive strategies, this report equips decision‐makers with actionable intelligence to navigate a rapidly changing environment and deliver superior patient care.

Transformative Shifts in the Landscape

The coronary artery device landscape is undergoing profound transformations driven by technological convergence and shifting care models. Digital processing has accelerated, enabling real‐time intravascular ultrasound analysis that enhances procedural precision and decision‐making. Simultaneously, bio‐absorbable materials have gained traction alongside established metallic and polymeric platforms, offering new trade‐offs between long‐term vessel healing and mechanical support. Within device design, balloon‐expandable and self‐expanding options cater to diverse lesion characteristics and patient anatomies, while plaque modification solutions, including atherectomy and thrombectomy systems, address complex occlusions beyond conventional angioplasty. End users-from ambulatory surgical centers to outpatient and cardiology clinics, and private or public hospitals-are redefining treatment pathways through shifting case volumes and reimbursement models. Moreover, population demographics skewing toward aging cohorts intensify demand for geriatric‐focused interventions with lower complication profiles. Taken together, these converging forces underscore a market in flux, where agility and innovation determine market leadership.

Cumulative Impact of United States Tariffs 2025

The United States’ 2025 tariff revisions have introduced new cost pressures and supply chain complexities for coronary artery disease treatment devices. Imports of bio‐absorbable materials and polymeric components now face differential levies, which vary across device categories such as drug‐eluting stents, bare metal stents, embolic protection devices and guidewires. Manufacturers relying on imported hydrophilic guidewire coatings or specialized theros thrombectomy blades must absorb or pass through incremental costs, potentially eroding margins. Meanwhile, domestic producers of balloon and guiding catheters, which utilize metallic materials sourced locally, may gain a competitive edge. Hospitals and clinics in border states have reported extended lead times and inventory challenges, prompting some providers to shift purchasing toward self‐expanding stents and atherectomy devices from domestic fabricators. As a result, supply chains are diversifying, with greater emphasis on local sourcing and near‐shoring of atherectomy electronics and intravascular imaging hardware. In this evolving fiscal environment, strategic partnerships and tariff‐mitigation tactics will be essential to maintain price competitiveness and device availability.

Key Segmentation Insights

Segmentation insights reveal nuanced growth drivers and adoption patterns across product types, end users, material types, applications, device designs, population demographics, and processing technologies. Catheters are bifurcated between balloon catheters, which deliver high‐pressure dilation for resistant lesions, and guiding catheters that ensure stable device navigation. Guidewires diversify into hydrophilic variants that glide through tortuous anatomy and polyethylene options offering consistent torque control. Occlusion management relies on embolic protection devices, while plaque modification spans atherectomy and thrombectomy solutions designed for calcified and thrombotic occlusions. Stent portfolios range from bare metal scaffolding to bio‐absorbable frameworks that resorb over time, and drug‐eluting models optimized for targeted pharmacotherapy. End users include ambulatory surgical centers, clinics segmented into cardiology and outpatient settings, and hospitals differentiated by private and public ownership. Material preferences split between bio‐absorbable, metallic and polymeric substrates, each influencing device performance and cost. Clinical applications focus on atherectomy, coronary angioplasty and valvuloplasty, and device designs optimize for balloon‐expandable or self‐expanding mechanisms. Demographic demands contrast adult and geriatric populations, while intravascular imaging leverages analog or digital processing to guide interventions. These intersecting axes underscore the importance of tailored strategies for product development, market access and clinical adoption.

Key Regional Insights

Regional dynamics in the coronary device market reflect heterogeneous healthcare infrastructures, reimbursement policies and disease prevalence across major geographies. In the Americas, established cardiology hubs in the United States drive innovation and volume, while Latin American countries pursue capacity expansion through catheterization lab upgrades and training initiatives. Europe, Middle East & Africa present divergent trends: Western Europe prioritizes minimally invasive procedures with advanced drug‐eluting and bio‐absorbable platforms, whereas emerging economies in Eastern Europe and the Gulf concentrate on increasing foundational interventional capabilities. In Africa, access remains constrained, yet targeted public‐private partnerships are accelerating device adoption. Asia-Pacific stands out for rapid market expansion, propelled by aging populations in Japan and China, growing angioplasty volumes in India, and government‐led healthcare modernization in Southeast Asia. Local manufacturing ecosystems in countries such as South Korea and Singapore further support regional supply, while cross‐border collaborations foster technology transfer. Collectively, these diverse market conditions shape competitive strategies and investment priorities for device manufacturers.

Key Companies Insights

The competitive landscape features global leaders that span diversified portfolios and regional specialists with focused expertise. Abbott Laboratories combines drug‐eluting stent leadership with digital coronary imaging solutions, while Medtronic PLC advances bio‐absorbable scaffolds and intravascular ultrasound systems. Boston Scientific Corporation drives innovation in atherectomy technologies alongside polymeric balloon catheter offerings. B. Braun Melsungen AG and Becton, Dickinson and Company maintain strength in guiding catheters and embolic protection devices, respectively, and Biotronik SE & Co. KG specializes in thrombectomy and analog intravascular imaging. Canon Medical Systems Corporation and FUJIFILM Holdings Corporation contribute high‐resolution intravascular ultrasound processing capabilities, mirrored by Philips N.V.’s digital platforms. GE Healthcare and Siemens Healthineers harness data analytics to enhance procedure planning, while Hitachi, Ltd. develops portable imaging systems. MicroPort Scientific Corporation brings competitive drug‐eluting and self‐expanding stent designs. Terumo Corporation offers hydrophilic guidewires and balloon‐expandable products, and Toshiba Corporation supports analog processing in emerging markets. This array of players underscores the importance of portfolio breadth and technological synergies in securing market share.

Actionable Recommendations for Industry Leaders

To thrive amid evolving clinical needs and policy environments, industry leaders must embrace a multi‐pronged strategy. First, accelerating local manufacturing and assembly capacities will mitigate tariff pressures, shorten supply chains and enable price flexibility. Second, bolstering research collaborations with academic centers and healthcare providers can fast‐track digital intravascular ultrasound processing enhancements, atherectomy device refinements and next‐generation stent coatings tailored to geriatric populations. Third, diversifying product portfolios across bio‐absorbable, metallic and polymeric materials will address varied patient profiles and care settings, from outpatient clinics to high‐volume hospitals. Fourth, forging strategic alliances with regional partners in Asia-Pacific, Latin America and the Gulf will unlock underserved markets and ensure compliance with evolving regulatory frameworks. Fifth, integrating real-world data analytics into post‐market surveillance and procedural guidance will enhance clinical outcomes and support differentiated value propositions for private and public payers. By prioritizing localization, innovation, portfolio depth, regional partnerships and data‐driven insights, companies can sustainably outperform competitors and strengthen device adoption across diverse care pathways.

Conclusion

The coronary artery device sector stands at a pivotal juncture, shaped by technological innovation, tariff realignments and shifting demographics. Segmentation and regional insights reveal significant opportunities in advanced imaging, bio‐absorbable stents and complex lesion management, while tariff impacts underscore the imperative for supply chain resilience. Competitive dynamics favor organizations that integrate clinical partnerships, localize production and leverage digital processing to refine device performance. As end users increasingly demand tailored solutions for outpatient and geriatric care, manufacturers must align R&D investments with emerging clinical protocols and reimbursement trends. In this context, strategic agility and collaborative execution will determine market leadership and long‐term growth.

Market Segmentation & Coverage

This research report categorizes the Coronary Artery Disease Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Catheters
    • Balloon Catheters
    • Guiding Catheters
  • Guidewires
    • Hydrophilic Guidewires
    • Polyethylene Guidewires
  • Occlusion Devices
    • Embolic Protection Devices
  • Plaque Modification Devices
    • Atherectomy Devices
    • Thrombectomy Devices
  • Stents
    • Bare Metal Stents
    • Bio-Absorbable Stents
    • Drug-Eluting Stents
  • Ambulatory Surgical Centers
  • Clinics
    • Cardiology Clinics
    • Outpatient Clinics
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Bio-Absorbable Materials
  • Metallic Materials
  • Polymeric Materials
  • Atherectomy
  • Coronary Angioplasty
  • Valvuloplasty
  • Balloon-Expandable
  • Self-Expanding
  • Adult Population
  • Geriatric Population
  • Analog Processing
  • Digital Processing

This research report categorizes the Coronary Artery Disease Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Coronary Artery Disease Treatment Devices Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • FUJIFILM Holdings Corporation
  • Ge Healthcare
  • Hitachi, Ltd.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Siemens Healthineer
  • Terumo Corporation
  • Toshiba Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Coronary Artery Disease Treatment Devices Market, by Product Type
8.1. Introduction
8.2. Catheters
8.2.1. Balloon Catheters
8.2.2. Guiding Catheters
8.3. Guidewires
8.3.1. Hydrophilic Guidewires
8.3.2. Polyethylene Guidewires
8.4. Occlusion Devices
8.4.1. Embolic Protection Devices
8.5. Plaque Modification Devices
8.5.1. Atherectomy Devices
8.5.2. Thrombectomy Devices
8.6. Stents
8.6.1. Bare Metal Stents
8.6.2. Bio-Absorbable Stents
8.6.3. Drug-Eluting Stents
9. Coronary Artery Disease Treatment Devices Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Clinics
9.3.1. Cardiology Clinics
9.3.2. Outpatient Clinics
9.4. Hospitals
9.4.1. Private Hospitals
9.4.2. Public Hospitals
10. Coronary Artery Disease Treatment Devices Market, by Material Type
10.1. Introduction
10.2. Bio-Absorbable Materials
10.3. Metallic Materials
10.4. Polymeric Materials
11. Coronary Artery Disease Treatment Devices Market, by Application
11.1. Introduction
11.2. Atherectomy
11.3. Coronary Angioplasty
11.4. Valvuloplasty
12. Coronary Artery Disease Treatment Devices Market, by Device Design
12.1. Introduction
12.2. Balloon-Expandable
12.3. Self-Expanding
13. Coronary Artery Disease Treatment Devices Market, by Population Demographics
13.1. Introduction
13.2. Adult Population
13.3. Geriatric Population
14. Coronary Artery Disease Treatment Devices Market, by Intravascular Ultrasound Processing
14.1. Introduction
14.2. Analog Processing
14.3. Digital Processing
15. Americas Coronary Artery Disease Treatment Devices Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Coronary Artery Disease Treatment Devices Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Coronary Artery Disease Treatment Devices Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories
18.3.2. B. Braun Melsungen AG
18.3.3. Becton, Dickinson and Company
18.3.4. Biotronik SE & Co. KG
18.3.5. Boston Scientific Corporation
18.3.6. Canon Medical Systems Corporation
18.3.7. FUJIFILM Holdings Corporation
18.3.8. Ge Healthcare
18.3.9. Hitachi, Ltd.
18.3.10. Koninklijke Philips N.V.
18.3.11. Medtronic PLC
18.3.12. MicroPort Scientific Corporation
18.3.13. Siemens Healthineer
18.3.14. Terumo Corporation
18.3.15. Toshiba Corporation
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET MULTI-CURRENCY
FIGURE 2. CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDING CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HYDROPHILIC GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POLYETHYLENE GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY THROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIO-ABSORBABLE STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CARDIOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BIO-ABSORBABLE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY METALLIC MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POLYMERIC MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ATHERECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CORONARY ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY VALVULOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY BALLOON-EXPANDABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY SELF-EXPANDING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ADULT POPULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GERIATRIC POPULATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY ANALOG PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DIGITAL PROCESSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 97. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 99. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 100. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 101. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 102. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 103. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 105. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 106. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 107. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 109. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 110. CANADA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 111. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 113. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 114. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 115. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 116. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 117. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 119. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 121. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 123. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 124. MEXICO CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 128. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 129. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 130. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 131. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 133. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 134. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 135. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 137. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 138. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 139. UNITED STATES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 143. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 144. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 145. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 146. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 148. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 149. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 150. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 152. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 153. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 154. ASIA-PACIFIC CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 157. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 158. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 159. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 160. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 161. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 163. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 164. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 165. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 167. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 168. AUSTRALIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 169. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 171. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 172. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 173. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 174. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 175. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 177. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 178. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 179. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 181. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 182. CHINA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 183. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 185. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 186. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 187. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 188. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 189. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 191. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 192. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 193. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 195. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 196. INDIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 206. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 207. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 209. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 210. INDONESIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 211. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 213. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 214. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 215. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 216. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 217. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 219. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 220. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 221. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 223. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 224. JAPAN CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 227. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 228. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 229. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 230. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 231. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 233. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 234. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 235. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 237. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 238. MALAYSIA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 241. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 242. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 243. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 244. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 245. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 247. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 248. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 249. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 255. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 256. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 257. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 258. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 259. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 261. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY POPULATION DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY INTRAVASCULAR ULTRASOUND PROCESSING, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 269. SOUTH KOREA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 270. SOUTH KOREA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY OCCLUSION DEVICES, 2018-2030 (USD MILLION)
TABLE 271. SOUTH KOREA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY PLAQUE MODIFICATION DEVICES, 2018-2030 (USD MILLION)
TABLE 272. SOUTH KOREA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 273. SOUTH KOREA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. SOUTH KOREA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
TABLE 275. SOUTH KOREA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 276. SOUTH KOREA CORONARY ARTERY DISEASE TREATMENT DEVICES MARKET SIZE, BY MATERIAL TYPE,

Companies Mentioned

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • FUJIFILM Holdings Corporation
  • Ge Healthcare
  • Hitachi, Ltd.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Siemens Healthineer
  • Terumo Corporation
  • Toshiba Corporation

Methodology

Loading
LOADING...